메뉴 건너뛰기




Volumn 55, Issue 4, 2011, Pages 933-935

Oral combination therapy: Future hepatitis C virus treatment?

Author keywords

[No Author keywords available]

Indexed keywords

BOCEPREVIR; DANOPREVIR; MERICITABINE; PEGINTERFERON; PLACEBO; RIBAVIRIN; TELAPREVIR; VIRUS RNA;

EID: 80052943313     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.04.018     Document Type: Note
Times cited : (4)

References (10)
  • 1
    • 79551525326 scopus 로고    scopus 로고
    • Big changes are coming in hepatitis C
    • F. Poordad Big changes are coming in hepatitis C Curr Gastroenterol Rep 13 2011 1906 1914
    • (2011) Curr Gastroenterol Rep , vol.13 , pp. 1906-1914
    • Poordad, F.1
  • 2
    • 78650928878 scopus 로고    scopus 로고
    • New direct-acting antivirals combination for the treatment of chronic hepatitis C
    • T. Asselah, and P. Marcellin New direct-acting antivirals combination for the treatment of chronic hepatitis C Liver Int 31 2011 68 77
    • (2011) Liver Int , vol.31 , pp. 68-77
    • Asselah, T.1    Marcellin, P.2
  • 7
    • 65449171953 scopus 로고    scopus 로고
    • Telaprevir and peginterferon with or without ribavirin for chronic HCV infection
    • C. Hézode, N. Forestier, G. Dusheiko, P. Ferenci, S. Pol, and T. Goeser Telaprevir and peginterferon with or without ribavirin for chronic HCV infection N Engl J Med 360 2009 1839 1850
    • (2009) N Engl J Med , vol.360 , pp. 1839-1850
    • Hézode, C.1    Forestier, N.2    Dusheiko, G.3    Ferenci, P.4    Pol, S.5    Goeser, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.